Acute Megakaryoblastic Leukemia - Explore the Science & Experts | ideXlab

Scan Science and Technology

Contact Leading Edge Experts & Companies

Acute Megakaryoblastic Leukemia

The Experts below are selected from a list of 285 Experts worldwide ranked by ideXlab platform

Acute Megakaryoblastic Leukemia – Free Register to Access Experts & Abstracts

Bruno Quesnel – One of the best experts on this subject based on the ideXlab platform.

  • Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
    Leukemia, 2007
    Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

  • successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
    Leukemia, 2007
    Co-Authors: Selim Corm, Bruno Quesnel, Aline Renneville, Nathalie Grardel, Claude Preudhomme, E Radquesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Selim Corm – One of the best experts on this subject based on the ideXlab platform.

  • Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
    Leukemia, 2007
    Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

  • successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
    Leukemia, 2007
    Co-Authors: Selim Corm, Bruno Quesnel, Aline Renneville, Nathalie Grardel, Claude Preudhomme, E Radquesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Aline Renneville – One of the best experts on this subject based on the ideXlab platform.

  • Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
    Leukemia, 2007
    Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

  • successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
    Leukemia, 2007
    Co-Authors: Selim Corm, Bruno Quesnel, Aline Renneville, Nathalie Grardel, Claude Preudhomme, E Radquesnel
    Abstract:

    Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation